Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Current Deferred Revenue (2020 - 2024)

National Healthcare's Current Deferred Revenue history spans 7 years, with the latest figure at $7.7 million for Q1 2024.

  • For Q1 2024, Current Deferred Revenue changed N/A year-over-year to $7.7 million; the TTM value through Mar 2024 reached $7.7 million, changed N/A, while the annual FY2021 figure was $15.0 million, 70.69% down from the prior year.
  • Current Deferred Revenue reached $7.7 million in Q1 2024 per NHC's latest filing, up from $138000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $51.3 million in Q3 2020 to a low of $138000.0 in Q3 2022.
  • Average Current Deferred Revenue over 4 years is $27.3 million, with a median of $27.0 million recorded in 2021.
  • Peak YoY movement for Current Deferred Revenue: fell 21.32% in 2021, then plummeted 99.49% in 2022.
  • A 4-year view of Current Deferred Revenue shows it stood at $51.3 million in 2020, then plummeted by 70.69% to $15.0 million in 2021, then tumbled by 99.08% to $138000.0 in 2022, then skyrocketed by 5455.8% to $7.7 million in 2024.
  • Per Business Quant, the three most recent readings for NHC's Current Deferred Revenue are $7.7 million (Q1 2024), $138000.0 (Q3 2022), and $586000.0 (Q2 2022).